chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours after my shot (April 24, 2019) I had a very sore arm much like most people I've talked to but then I had the sensation of being really cold - enough that I couldn't sleep, so I got up and put a heating pad on and numerous layers of cold. Was able to sleep that night. Then on April 28th at around 11:00 pm I got the same sensation but much more significant. It felt like my entire legs were frozen. They were not cold to the touch but the sensation in my skin was that they were very very cold. I could not warm up. 3 shirts, pants, wool socks, 2 blankets - one of them a down comforter - a microwave heated pad and an electric heated pad and I still felt very very cold. No shaking or shivering. No fever. No sweating. My temperature was 97.7 which is what it usually is. Eventually fell asleep but when I got up in the morning (April 29) the cold sensation remained and is now in my arms as well. Took a hot shower but still can't "feel" warm. Sat under multiple blankets and started sweating but never felt hot or even warm. Still no change in temperature and no shivering. Just a very cold sensation - like someone has blasted my legs and upper arms with an air conditioning unit. As of 10:15am on April 29th, these symptoms remain unchanged.
Patient and mother returned to the health dept. complaining of sudden sharp progressive pain in upper right deltoid region.  Stated pain begain one week after administration of vaccine with dull pain and progressing to sharp pain with upper movement of arm.  Patient also c/o headache and 3 itching bumps.  RN examined and appeared to be possible chicken pox vesicles.  Told patient to cover and not scratch vesicles further and apply warm compress to upper deltoid region and to see physician should the pain in her shoulder continue or progress.
Initial report received from a vaccine provider on 07 January 2013. This case is not medically confirmed as the reporter was not identified as a healthcare professional or not. The report involves a cluster of 6 children from the same reporter and same lot number UH753AB. This case captures one of the children and the other children are captured in cases 2012-11111, 2013-00526, 2013-00527, 2013-00528 and 2013-00529. A three year-old female patient whose illness at the time of vaccination was reported as "N/A" and past medical history was unknown had received a dose of FLUZONE (lot number UH753AB, IM) on 04 October 2012 and tested positive for Influenza A and influenza B via the Binaxnow quick test on 03 December 2012. The patient's outcome was not recovered. Documents held by sender: none.
Patient described fever at onset 101.1 F up to 103.3 F over a period of approximately 48 hours.  Patient was seen in local emergency room times 2 with reactive work ups and diagnosed with fever of unknown origin.  Patient was treated with Ibuprofen and acetaminophen.
Small red maculopapular rash started on neck on 2/19/03. Increased to papulo-pustules on neck, ears and trunk on 2/20. Itching, given Benadryl with some ?? on itching but developed large erythematous confluent plane? ?? central clean over entire body w/swelling of face wrists and feet.  Treated with Benadryl, steroids for prescribed? EM. Awaiting response to Tx.
pneumonia vax sore, redness that eve 4cm circumference rt tricep raised that eve; took ASA; 3DEC am redness & tenderness inc elbow-bicep;
starting vomiting @ 3PM during noc had fever 100 next day broke out in hives all over fever 102 starting Sunday sick until Wednesday feeling OK Thursday p/4days;
This spontaneous report as received from a pharmacist refers to an unspecified patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with the first dose of ZOSTAVAX (dose, route of administration, lot# and expiry date were unknown) for prophylaxis. On an unspecified date, reported as over a year after the first dose, the patient was administrated with the second dose of ZOSTAVAX, lot# M035691, expiry date 07-NOV-2017 (dose and route of administration were not reported) for prophylaxis. The lot of the sterile diluent used was M023649 with an expiry date of 14-DEC-2018. There were no adverse effects reported. No product quality complaint was involved. Additional information has been requested.
Condition aggravated; Stress; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated) and STRESS (Stress) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis, Ankylosing spondylitis and Plaque psoriasis.    No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated) and STRESS (Stress). At the time of the report, CONDITION AGGRAVATED (Condition aggravated) and STRESS (Stress) outcome was unknown.            No concomitant medications was reported.  On unknown dates, the patient experienced flare up after went through stressing events in life and covid vaccine caused bad reaction/ flare up developed worst condition.  No treatment medications was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna.
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness) and ARTHRALGIA (Joint pains) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 immunisation.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 Vaccine (The same as the reactions he had with Pfizer COVID-19 Vaccine.) and Pfizer COVID-19 Vaccine (The same as the reactions he had with Pfizer COVID-19 Vaccine.). Past adverse reactions to the above products included Joint pain with Pfizer COVID-19 Vaccine; and Sickness with Pfizer COVID-19 Vaccine.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness) and ARTHRALGIA (Joint pains). At the time of the report, ILLNESS (Sickness) outcome was unknown and ARTHRALGIA (Joint pains) had not resolved.            No concomitant medication was provided.  Patient had experienced joint pains, sickness and it reportedly lasted for a long time.  At the time of report, the patient still had those joint pains.  Treatment medication was not provided by the reporter.   Reporter did not allow further contact
This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 17-year-old female patient who received BEXSERO. On 21st July 2017, the patient received BEXSERO. On 21st July 2017, less than a day after receiving BEXSERO, the patient experienced injection site pain. On 22nd July 2017, the patient experienced injected limb mobility decreased, injection site erythema and injection site lump. On an unknown date, the outcome of the injected limb mobility decreased, injection site pain, injection site erythema and injection site lump were not recovered/not resolved. The reporter considered the injected limb mobility decreased, injection site pain, injection site erythema and injection site lump to be related to BEXSERO. Additional details were provided as follows: The case was reported by the patient's mother. The injection site was very bad on Friday night and ice was applied. On next day, the patient could barely move her arm and the patient's mother put it in a sling. The area was red and there is a lump where the pain is located.
Fever; blood in toilet after urination; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and BLOOD URINE PRESENT (blood in toilet after urination) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (Fever) and BLOOD URINE PRESENT (blood in toilet after urination). At the time of the report, PYREXIA (Fever) and BLOOD URINE PRESENT (blood in toilet after urination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments  Concomitant medication not provided.  Treatment information not provided.
About 5 mins after vaccination, pt appeared to being having a seizure: her whole body was stiff--arms and legs and torso board straight, eyes wide open but not seeing anything and her whole body was tremoring.  All color had drained from her face.  It lasted about 20-25 seconds.  When it stopped she asked where she was and what had happened.  She was breathing hard and and was very warm to the touch and reported that she felt like she had been watching TV.  Her arms and legs were tingling for about 10 mins after.  EMS was called and responded but pt refused to go to hospital.  Per self-report she has never had a seizure before
Flu like symptoms, pain in injection site, headache, dizziness, sore throat, fatigue.
fatigue on onset.  7th day, left arm felt heavy, tingly, injection site had a lump, red with lumps inside the lump.  Went to clinic 01/05/21, Dr marked the site. Advised to apply ice and use topical benedryl (I did not have at home). Next day, worsened, injection site, very red, itchy, burning, and had redness had spread beyond the markings of Dr. On 01/06/21 went to clinic, saw PAC. Put me on antibiotics.  Stated allergic reaction and looked like cellulitis too.  Today arm is less swollen, but still red and itchy. Going back to clinic to see Dr Friday 01/08/21 at 10:30 am
Arm turned red from the area where the shot was given to her elbow. Arm swelled to twice its normal size. Arm hurt within her body and on the surface of the skin. Patient went to Urgent Care and received steroid shot on 10/17/19 + oral prednisone to take. Arm back to normal 10/19/19.
One day after my initial COVID 19 Pfizer shot, I started to get a red rash on my entire chest.
MIGRAINES; MUSCLE ACHES; This spontaneous report received from a patient via a company representative concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced migraines, and muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the migraines and muscle aches was not reported. This report was non-serious.
Body aches, headache, stomach ache, chills, nauseous, all at 9:00 pm 1/7/2021
Was told she died in her sleep.  This is one of 3 nurses in the medical center that passed away suddenly.  Vaccine roll out was December 2020, unknown exact date or type
1/22 - near syncope 2/7 - right axillary lymphadenopathy 2/8 - petichiae to right earlobe
Woke up from nap approximately few hours after vaccine crying. Cried for 2 hours. Difficult to console. Brought back to office. Given Tylenol and heat packs and swaddled. Calmed and stayed cal within 30 minutes. Did vomit during crying. Next day, developed temp < 101 (was 100.2), vomiting, and diarrhea. Admitted to hospital after septic work up. Diarrhea persisted for 2 weeks.
Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; This is a spontaneous report from a contactable Nurse (patient). A 55-year-old female patient (No pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Intramuscular on 22Dec2020 10:30 AM on Right arm for COVID-19 immunization. Medical history was diagnosed with COVID-19 prior to vaccination. Concomitant drug was not reported. No other vaccine in four weeks. Adverse event reported as Headache, body aches, fatigue, injection site pain (all was non-serious) on 23Dec2020 12:00 AM with outcome was Recovering. No treatment. No COVID prior vaccination. No COVID tested post vaccination. Since the vaccination, the patient was not been tested for COVID-19. Information about lot/batch number are requested.
I have chronic ITP but platelets have been fine for 12+ years. After first dose two weeks later my platelets dropped to 4,000 and had to be hospitalized
convulsions; Uncontrollable movement on her face / Uncontrollable movement of entire body; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (convulsions) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 648B21A and 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced SEIZURE (convulsions) (seriousness criterion medically significant) and DYSKINESIA (Uncontrollable movement on her face / Uncontrollable movement of entire body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg. At the time of the report, SEIZURE (convulsions) and DYSKINESIA (Uncontrollable movement on her face / Uncontrollable movement of entire body) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  It was reported that the patient started experiencing uncontrollable movement on her face and entire body, it like convulsions almost. The pharmacist was not sure what she could use to help it but she was told to use Benadryl 25mg. She is still having the symptoms bad.  This case concerns a 26-year-old female with a serious unexpected event of seizure, and non-serious dyskinesia. Event latency 7 days after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 26-year-old female with a serious unexpected event of seizure, and nonserious dyskinesia. Event latency 7 days after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
DTap positive reaction: 2 in by 3 in welt, which increased in size the next day. Seen at Urgent Care. Diagnosed as cellulitis. On Cefzil 250 BID for 10 days. Much improved by next day. To be reviewed after medication finished.
Congestive heart failure; Couldn't breathe in and had short breaths/shortness of breath hit him; Swelling got up his leg; ankles, knees swollen; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FAILURE CONGESTIVE (Congestive heart failure) and DYSPNOEA (Couldn't breathe in and had short breaths/shortness of breath hit him) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CARDIAC FAILURE CONGESTIVE (Congestive heart failure) (seriousness criterion hospitalization), DYSPNOEA (Couldn't breathe in and had short breaths/shortness of breath hit him) (seriousness criterion hospitalization prolonged), PERIPHERAL SWELLING (Swelling got up his leg) and JOINT SWELLING (ankles, knees swollen). The patient was hospitalized for 5 days due to CARDIAC FAILURE CONGESTIVE and DYSPNOEA. At the time of the report, CARDIAC FAILURE CONGESTIVE (Congestive heart failure), DYSPNOEA (Couldn't breathe in and had short breaths/shortness of breath hit him), PERIPHERAL SWELLING (Swelling got up his leg) and JOINT SWELLING (ankles, knees swollen) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: no evidence of blood clot no evidence of blood clot.         No concomitant medications provided.  Treatment of these events included oxygen.  Action taken with mRNA-1273 in response to the events was not applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-089692 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-089692:
A nurse got Bell's Palsy after the vaccine; heart attack; This is a spontaneous report from a contactable consumer. A female patient (nurse) of an unspecified age received single dose of BNT162B2 (batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for immunization. The patient's medical history and concomitant medications were not reported. The consumer asked if Pfizer have more information if so then what's the ingredients. States that "injury lawyers know how many deaths because of the vaccine. Bell's palsy, a nurse got Bell Palsy after the vaccine, she is all distorted, and 30 days later, that's the 2nd one to have a heart attack." The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.
Hives over entire body, torso, arms, legs, heal. Went to urgent care and was referred to ER. ER prescribed PREDNISONE. Pt has experienced a complete recovery.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 006M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included ESCITALOPRAM, LAMOTRIGINE and CLONAZEPAM for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, SARS-CoV-2 test: positive (Positive) positive.         Patient called on  23March 2021 to report testing positive for COVID-19 after completing the Moderna COVID-19 vaccination series.    According to patient, two of her family members who have not been vaccinated tested positive for COVID-19 and that is why she went to get tested. She did the test yesterday and got the results as positive today.    Patient asked if she the vaccine can give her the virus and why did she tested positive if she has completed the series and has antibodies.  No treatment information were provided.
Patient received Zostavax on 12/20/07 from the Pharmacy.  The patient has diabetes.  Blood glucose level increased on 12/21/07.  Levels remained elevated for four days and then returned to normal.  Other than the blood glucose levels being high, the patient had no other symptoms.
High fever, nuchal rigidity, injection site induration, nausea, severe headaches, photophobia.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: patient was pale and chills at store after received shot - sat on floor because felt was going to pass out
Patient was brought to the ED by EMS on 12/11/22 for weakness and nausea that had been going on for about three days. She notes that she recently received her COVID vaccine a few days ago (12/8/22). Workup in the ED revealed UTI, NSTEMI, and A fib with RVR. A COVID PCR test also resulted positive. Ultimately patient was admitted 12/11/22 - 12/21/22, with discharge diagnoses including NSTEMI with cardiomyopathy and acute respiratory failure with hypoxia likely due to combination of COVID-19 infection and congestive heart failure, among other discharge diagnoses. During admission, the patient required supplemental oxygen, but was able to be weaned off. Patient is fully vaccinated.
Narrative: Patient contacted telephone triage nurse today requesting appt with  provider for c/o R knee pain. Onset 2 months ago after receiving covid vaccine,  gradually worsening, "more so the past few days." (Rating pain "8"/10 today). Denies known injury. States pain has localized to posterior knee, "right behind the  knee, feels warm to touch." No erythema or rashes. Patient coincidentally mentions his calf area is swollen, in addition to the knee, "The calf indents when I push on it - started hurting after that vaccine that I got in March, but it's really gotten more painful and swollen the few days - just kept hoping it would go away." No prior h/o DVT. States symptoms started after he was given the first COVID vaccine (moderna) in March, received the second dose in April. Pt is also c/o chest pain, "When I take a deep breath - that just started today." + New cough, "bringing up some thick whitish stuff today, and just feel a little short of breath today when I get up and walk around." No wheezing. Again, recommended local ER, states he will go to ER now.